Search Results

PHT-427 200mg 200mg  | Purity Not Available

Adooq Bioscience

PHT-427 is a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.

More Information Supplier Page

PHT-427 100mg 100mg  | Purity Not Available

Adooq Bioscience

PHT-427 is a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.

More Information Supplier Page

A-674563 10mg 10mg  | Purity Not Available

Adooq Bioscience

A-674563 is a B/Akt inhibitor with an IC50 of 14 nM and also shows inhibitory activity against PKA and CDK2 with IC50 of 16 and 46 nM, respectively.

More Information Supplier Page

A-674563 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

A-674563 is a B/Akt inhibitor with an IC50 of 14 nM and also shows inhibitory activity against PKA and CDK2 with IC50 of 16 and 46 nM, respectively.

More Information Supplier Page

LY2603618 10mg 10mg  | Purity Not Available

Adooq Bioscience

LY2603618 is a chk2 inhibitor that binds to and inhibits the activity of chk2, which may prevent the repair of DNA caused by DNA-damaging agents.

More Information Supplier Page

GSK2126458 50mg 50mg  | Purity Not Available

Adooq Bioscience

GSK2126458 is a highly potent, orally bioavailable inhibitor of PI3K?? and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.

More Information Supplier Page

GSK2126458 5mg 5mg  | Purity Not Available

Adooq Bioscience

GSK2126458 is a highly potent, orally bioavailable inhibitor of PI3K?? and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.

More Information Supplier Page

GSK2126458 2mg 2mg  | Purity Not Available

Adooq Bioscience

GSK2126458 is a highly potent, orally bioavailable inhibitor of PI3K?? and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.

More Information Supplier Page

GSK2126458 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

GSK2126458 is a highly potent, orally bioavailable inhibitor of PI3K?? and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.

More Information Supplier Page